Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors [Phase 1]
Phase 1 clinical trial update for NW-101C, a TCR-engineered T cell therapy by Neowise Biotechnology, targeting metastatic solid tumors; recr…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of GC203 TIL in Advanced Malignant Solid Tumors [Phase 1]
This Phase 1 study of GC203 TIL in advanced malignant solid tumors is currently recruiting across multiple cancer types, including gynecolog…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
A completed clinical trial (NCT05790538) investigating methods to predict how cancer treatment toxicities affect patients' health.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment [Phase 1, Phase 2]
Clinical trial update for neratinib in children and young adults with cancer, focusing on safety and dose finding in Phase 1/Phase 2.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating selinexor in Wilms tumor, rhabdoid tumors, and other solid tumors is currently recruiting at Memorial Sl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol [Phase 2, Phase 3]
The DETERMINE master screening protocol is a platform trial designed to determine extended therapeutic indications for existing drugs in rar…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers [Phase 2, Phase 3]
The DETERMINE trial treatment arm 01 is evaluating Alectinib in adult, paediatric and teenage/young adult patients with ALK-positive cancers…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on the safety and tolerability of an mRNA vaccine encoding tumor-specific circular RNA antigens in combination with an…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Expressive Writing for the Management of Stress in Cancer Survivors [NA]
The study 'Expressive Writing for the Management of Stress in Cancer Survivors' is currently recruiting, sponsored by MD Anderson Cancer Cen…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating LAM561 Acid in pediatric patients with malignant glioma and other advanced solid tumors is currently r…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: SB17170 Phase 1 Clinical Trial in Solid Tumors [Phase 1]
This clinical trial update notes that SB17170 is in a Phase 1 study for solid tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study of MHB036C for Advanced Solid Tumor [Phase 1, Phase 2]
This update describes a Phase 1/Phase 2 study of the experimental cancer therapy MHB036C for advanced solid tumors, with the trial currently…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: First in Human, Dose Escalation Study of AN4005 [Phase 1]
First-in-human, dose-escalation study of AN4005 in patients with advanced solid tumors and advanced lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. [EARLY_Phase 1]
Clinical trial update indicating TGW211 as a click-cleavable imaging agent for HER2-positive cancers in an early-phase 1 study, currently re…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors [Phase 2]
This clinical trial update describes a Phase 2 study evaluating MHB036C in combination with MHB039A in patients with advanced breast cancer …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies [Phase 1]
Phase 1 study evaluating the safety and tolerability of GEH200520/GEH200521 (18F) as a PET imaging tracer in patients with solid tumors; cur…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment [Phase 1]
Aadi Bioscience is conducting a Phase 1 dose-escalation study to assess the safety and pharmacokinetics of Nab-Sirolimus in patients with lo…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: A Study of YL201 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the investigational drug YL201 in patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating salvage radiation therapy for patients with metastatic cancer that progressed after systemic immunotherapy…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946 [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating the safety, tolerability, PK and anti-tumor activity of YH42946 in non-small cell lung cancer and othe…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Study of ASP1012 in Adults With Solid Tumors [Phase 1]
A Phase 1 study of ASP1012 in adults with solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M) [Phase 2]
A phase 2 MATCH subprotocol M trial update evaluating MLN0128 (TAK-228) as a targeted treatment for cancers with TSC1 or TSC2 genetic change…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N) [Phase 2]
Phase 2 MATCH subprotocol update evaluating GSK2636771 for cancers with PTEN genetic changes; results were posted in 2025.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. [Phase 4]
This Phase 4 trial update describes extending ibrutinib treatment for patients who continue to benefit from the therapy.
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy [NA]
A completed clinical trial evaluated acupressure as a method to reduce anxiety in patients undergoing chemotherapy.